Literature DB >> 9544950

Will xenotransplantation ever be feasible?

T E Starzl1, A S Rao, N Murase, J Fung, A J Demetris.   

Abstract

In several recent conferences, the principal questions have been whether xenotransplantation technology should be encouraged and, if so, how it should be regulated. Because the prospect of successful transplantation of animal organs into humans is still remote, the rush to achieve consensus about clinical application would be inexplicable were it not for two ostensibly unrelated issues. The first is the small but undeniable theoretical hazard of causing new human infections with the intermingling of tissues from different species. The second, advanced by animal-rights advocates, concerns the spiritual and ethical relationship of humans to animals.

Entities:  

Mesh:

Year:  1998        PMID: 9544950      PMCID: PMC2744293          DOI: 10.1016/s1072-7515(98)00053-2

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  27 in total

Review 1.  Cell migration, chimerism, and graft acceptance.

Authors:  T E Starzl; A J Demetris; N Murase; S Ildstad; C Ricordi; M Trucco
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

2.  RENAL HETEROTRANSPLANTATION FROM BABOON TO MAN: EXPERIENCE WITH 6 CASES.

Authors:  T E STARZL; T L MARCHIORO; G N PETERS; C H KIRKPATRICK; W E WILSON; K A PORTER; D RIFKIND; D A OGDEN; C R HITCHCOCK; W R WADDELL
Journal:  Transplantation       Date:  1964-11       Impact factor: 4.939

Review 3.  Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance.

Authors:  T E Starzl; A J Demetris; M Trucco; N Murase; C Ricordi; S Ildstad; H Ramos; S Todo; A Tzakis; J J Fung
Journal:  Hepatology       Date:  1993-06       Impact factor: 17.425

4.  A biological role for the major histocompatibility antigens.

Authors:  P C Doherty; R M Zinkernagel
Journal:  Lancet       Date:  1975-06-28       Impact factor: 79.321

5.  Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs.

Authors:  N Murase; T E Starzl; A J Demetris; L Valdivia; M Tanabe; D Cramer; L Makowka
Journal:  Transplantation       Date:  1993-04       Impact factor: 4.939

Review 6.  Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody.

Authors:  U Galili
Journal:  Springer Semin Immunopathol       Date:  1993

7.  Baboon-to-human liver transplantation.

Authors:  T E Starzl; J Fung; A Tzakis; S Todo; A J Demetris; I R Marino; H Doyle; A Zeevi; V Warty; M Michaels
Journal:  Lancet       Date:  1993-01-09       Impact factor: 79.321

8.  Baboon-to-human cardiac xenotransplantation in a neonate.

Authors:  L L Bailey; S L Nehlsen-Cannarella; W Concepcion; W B Jolley
Journal:  JAMA       Date:  1985-12-20       Impact factor: 56.272

9.  Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement.

Authors:  D J White; T Oglesby; M K Liszewski; I Tedja; D Hourcade; M W Wang; L Wright; J Wallwork; J P Atkinson
Journal:  Transpl Int       Date:  1992       Impact factor: 3.782

10.  Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1----3Gal epitope in primates.

Authors:  U Galili; M R Clark; S B Shohet; J Buehler; B A Macher
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

View more
  5 in total

1.  The birth of clinical organ transplantation.

Authors:  T E Starzl
Journal:  J Am Coll Surg       Date:  2001-04       Impact factor: 6.113

2.  Hepatic and intestinal transplantation at the University of Pittsburgh.

Authors:  K Abu-Elmagd; J Fung; J Reyes; A Rao; A Jain; G Mazariegos; W Marsh; J Madariaga; I Dvorchik; J Bueno; J Rogers; J McMichael; F Dodson; H Vargus; J Martin; A Slivka; V Balan; R Corry; J Rakela; N Murase; J Demetris; S Iwatsuki; T Starzl
Journal:  Clin Transpl       Date:  1998

Review 3.  Regulation of immune reactivity and tolerance by antigen migration and localization: with particular reference to allo- and xenotransplantation.

Authors:  T E Starzl; N Murase; A W Thomson; M Trucco; A Rao
Journal:  Transplant Proc       Date:  1999-06       Impact factor: 1.066

4.  History of clinical transplantation.

Authors:  T E Starzl
Journal:  World J Surg       Date:  2000-07       Impact factor: 3.352

5.  Xenoantigen Deletion and Chemical Immunosuppression Can Prolong Renal Xenograft Survival.

Authors:  Andrew B Adams; Steven C Kim; Gregory R Martens; Joseph M Ladowski; Jose L Estrada; Luz M Reyes; Cindy Breeden; Allison Stephenson; Devin E Eckhoff; Matt Tector; Alfred Joseph Tector
Journal:  Ann Surg       Date:  2018-10       Impact factor: 12.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.